Report Detail
Global Human iPSCs Market Growth (Status and Outlook) 2021-2026
- RnM4358939 |
- 16 December, 2021 |
- Global |
- 87 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
According to this latest study, the 2021 growth of Human iPSCs will have significant change from previous year. By the most conservative estimates of global Human iPSCs market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the Human iPSCs market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Human iPSCs market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Skin
Blood Cells
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Academic Research
Drug Development and Discovery
Toxicity Screening
Regenerative Medicine
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Fujifilm Holding Corporation (CDI)
Ncardia
Sumitomo Dainippon Pharma
Astellas Pharma Inc
Fate Therapeutics, Inc
Pluricell Biotech
Cell Inspire Biotechnology
ReproCELL
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Human iPSCs Market Size 2016-2026
- 2.1.2 Human iPSCs Market Size CAGR by Region 2020 VS 2021 VS 2026
- 2.2 Human iPSCs Segment by Type
- 2.2.1 Skin
- 2.2.2 Skin
- 2.3 Human iPSCs Market Size by Type
- 2.3.1 Global Human iPSCs Market Size CAGR by Type
- 2.3.2 Global Human iPSCs Market Size Market Share by Type (2016-2021)
- 2.4 Human iPSCs Segment by Application
- 2.4.1 Academic Research
- 2.4.2 Drug Development and Discovery
- 2.4.3 Toxicity Screening
- 2.4.4 Regenerative Medicine
- 2.4.5 Others
- 2.5 Human iPSCs Market Size by Application
- 2.5.1 Global Human iPSCs Market Size CAGR by Application
- 2.5.2 Global Human iPSCs Market Size Market Share by Application (2016-2021)
3 Human iPSCs Market Size by Players
- 3.1 Human iPSCs Market Size Market Share by Players
- 3.1.1 Global Human iPSCs Revenue by Players (2019-2021E)
- 3.1.2 Global Human iPSCs Revenue Market Share by Players (2019-2021E)
- 3.2 Global Human iPSCs Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Human iPSCs by Regions
- 4.1 Human iPSCs Market Size by Regions (2016-2021)
- 4.2 Americas Human iPSCs Market Size Growth (2016-2021)
- 4.3 APAC Human iPSCs Market Size Growth (2016-2021)
- 4.4 Europe Human iPSCs Market Size Growth (2016-2021)
- 4.5 Middle East & Africa Human iPSCs Market Size Growth (2016-2021)
5 Americas
- 5.1 Americas Human iPSCs Market Size by Country (2016-2021)
- 5.2 Americas Human iPSCs Market Size by Type (2016-2021)
- 5.3 Americas Human iPSCs Market Size by Application (2016-2021)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Human iPSCs Market Size by Region (2016-2021)
- 6.2 APAC Human iPSCs Market Size by Type (2016-2021)
- 6.3 APAC Human iPSCs Market Size by Application (2016-2021)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Human iPSCs by Country (2016-2021)
- 7.2 Europe Human iPSCs Market Size by Type (2016-2021)
- 7.3 Europe Human iPSCs Market Size by Application (2016-2021)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Human iPSCs by Region (2016-2021)
- 8.2 Middle East & Africa Human iPSCs Market Size by Type (2016-2021)
- 8.3 Middle East & Africa Human iPSCs Market Size by Application (2016-2021)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Human iPSCs Market Forecast
- 10.1 Global Human iPSCs Forecast by Regions (2021-2026)
- 10.1.1 Global Human iPSCs Forecast by Regions (2021-2026)
- 10.1.2 Americas Human iPSCs Forecast
- 10.1.3 APAC Human iPSCs Forecast
- 10.1.4 Europe Human iPSCs Forecast
- 10.1.5 Middle East & Africa Human iPSCs Forecast
- 10.2 Americas Human iPSCs Forecast by Countries (2021-2026)
- 10.2.1 United States Human iPSCs Market Forecast
- 10.2.2 Canada Human iPSCs Market Forecast
- 10.2.3 Mexico Human iPSCs Market Forecast
- 10.2.4 Brazil Human iPSCs Market Forecast
- 10.3 APAC Human iPSCs Forecast by Region (2021-2026)
- 10.3.1 China Human iPSCs Market Forecast
- 10.3.2 Japan Human iPSCs Market Forecast
- 10.3.3 Korea Human iPSCs Market Forecast
- 10.3.4 Southeast Asia Human iPSCs Market Forecast
- 10.3.5 India Human iPSCs Market Forecast
- 10.3.6 Australia Human iPSCs Market Forecast
- 10.4 Europe Human iPSCs Forecast by Country (2021-2026)
- 10.4.1 Germany Human iPSCs Market Forecast
- 10.4.2 France Human iPSCs Market Forecast
- 10.4.3 UK Human iPSCs Market Forecast
- 10.4.4 Italy Human iPSCs Market Forecast
- 10.4.5 Russia Human iPSCs Market Forecast
- 10.5 Middle East & Africa Human iPSCs Forecast by Region (2021-2026)
- 10.5.1 Egypt Human iPSCs Market Forecast
- 10.5.2 South Africa Human iPSCs Market Forecast
- 10.5.3 Israel Human iPSCs Market Forecast
- 10.5.4 Turkey Human iPSCs Market Forecast
- 10.5.5 GCC Countries Human iPSCs Market Forecast
- 10.6 Global Human iPSCs Forecast by Type (2021-2026)
- 10.7 Global Human iPSCs Forecast by Application (2021-2026)
11 Key Players Analysis
- 11.1 Fujifilm Holding Corporation (CDI)
- 11.1.1 Fujifilm Holding Corporation (CDI) Company Information
- 11.1.2 Fujifilm Holding Corporation (CDI) Human iPSCs Product Offered
- 11.1.3 Fujifilm Holding Corporation (CDI) Human iPSCs Revenue, Gross Margin and Market Share (2019-2021)
- 11.1.4 Fujifilm Holding Corporation (CDI) Main Business Overview
- 11.1.5 Fujifilm Holding Corporation (CDI) Latest Developments
- 11.2 Ncardia
- 11.2.1 Ncardia Company Information
- 11.2.2 Ncardia Human iPSCs Product Offered
- 11.2.3 Ncardia Human iPSCs Revenue, Gross Margin and Market Share (2019-2021)
- 11.2.4 Ncardia Main Business Overview
- 11.2.5 Ncardia Latest Developments
- 11.3 Sumitomo Dainippon Pharma
- 11.3.1 Sumitomo Dainippon Pharma Company Information
- 11.3.2 Sumitomo Dainippon Pharma Human iPSCs Product Offered
- 11.3.3 Sumitomo Dainippon Pharma Human iPSCs Revenue, Gross Margin and Market Share (2019-2021)
- 11.3.4 Sumitomo Dainippon Pharma Main Business Overview
- 11.3.5 Sumitomo Dainippon Pharma Latest Developments
- 11.4 Astellas Pharma Inc
- 11.4.1 Astellas Pharma Inc Company Information
- 11.4.2 Astellas Pharma Inc Human iPSCs Product Offered
- 11.4.3 Astellas Pharma Inc Human iPSCs Revenue, Gross Margin and Market Share (2019-2021)
- 11.4.4 Astellas Pharma Inc Main Business Overview
- 11.4.5 Astellas Pharma Inc Latest Developments
- 11.5 Fate Therapeutics, Inc
- 11.5.1 Fate Therapeutics, Inc Company Information
- 11.5.2 Fate Therapeutics, Inc Human iPSCs Product Offered
- 11.5.3 Fate Therapeutics, Inc Human iPSCs Revenue, Gross Margin and Market Share (2019-2021)
- 11.5.4 Fate Therapeutics, Inc Main Business Overview
- 11.5.5 Fate Therapeutics, Inc Latest Developments
- 11.6 Pluricell Biotech
- 11.6.1 Pluricell Biotech Company Information
- 11.6.2 Pluricell Biotech Human iPSCs Product Offered
- 11.6.3 Pluricell Biotech Human iPSCs Revenue, Gross Margin and Market Share (2019-2021)
- 11.6.4 Pluricell Biotech Main Business Overview
- 11.6.5 Pluricell Biotech Latest Developments
- 11.7 Cell Inspire Biotechnology
- 11.7.1 Cell Inspire Biotechnology Company Information
- 11.7.2 Cell Inspire Biotechnology Human iPSCs Product Offered
- 11.7.3 Cell Inspire Biotechnology Human iPSCs Revenue, Gross Margin and Market Share (2019-2021)
- 11.7.4 Cell Inspire Biotechnology Main Business Overview
- 11.7.5 Cell Inspire Biotechnology Latest Developments
- 11.8 ReproCELL
- 11.8.1 ReproCELL Company Information
- 11.8.2 ReproCELL Human iPSCs Product Offered
- 11.8.3 ReproCELL Human iPSCs Revenue, Gross Margin and Market Share (2019-2021)
- 11.8.4 ReproCELL Main Business Overview
- 11.8.5 ReproCELL Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Human iPSCs. Industry analysis & Market Report on Human iPSCs is a syndicated market report, published as Global Human iPSCs Market Growth (Status and Outlook) 2021-2026. It is complete Research Study and Industry Analysis of Human iPSCs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
